Shanghai Fosun Pharmaceutical Group Co Ltd historical data
| Date | Open | High | Low | Close | Adj. close | Volume |
|---|---|---|---|---|---|---|
| 2026-10-20 | 17.220 | 17.320 | 16.860 | 17.080 | 17.080 | 1,685,500 |
| 2026-10-16 | 17.320 | 17.550 | 16.880 | 17.110 | 17.110 | 2,252,500 |
| 2026-10-15 | 17.130 | 17.410 | 17.010 | 17.150 | 17.150 | 1,762,565 |
| 2026-10-14 | 17.370 | 17.500 | 17.210 | 17.220 | 17.220 | 1,292,000 |
| 2026-10-13 | 17.390 | 17.580 | 17.020 | 17.510 | 17.510 | 2,945,200 |
| 2026-10-12 | 17.880 | 17.990 | 17.220 | 17.260 | 17.260 | 3,663,729 |
| 2026-10-09 | 17.860 | 17.920 | 17.620 | 17.870 | 17.870 | 2,851,500 |
| 2026-10-08 | 18.270 | 18.500 | 17.800 | 17.820 | 17.820 | 3,658,000 |
| 2026-10-07 | 18.600 | 18.600 | 17.710 | 18.190 | 18.190 | 1,520,200 |
| 2026-10-06 | 18.240 | 18.300 | 17.950 | 18.290 | 18.290 | 828,500 |
| 2026-10-05 | 18.180 | 18.360 | 17.700 | 17.860 | 17.860 | 645,000 |
| 2026-10-02 | 18.650 | 18.650 | 17.680 | 18.160 | 18.160 | 954,093 |
| 2026-09-30 | 17.880 | 18.610 | 17.640 | 18.470 | 18.470 | 5,097,724 |
| 2026-09-29 | 17.860 | 18.150 | 17.690 | 17.870 | 17.870 | 2,968,591 |
| 2026-09-28 | 17.510 | 17.830 | 17.510 | 17.640 | 17.640 | 2,129,695 |
| 2026-09-25 | 17.590 | 17.590 | 17.080 | 17.390 | 17.390 | 458,500 |
| 2026-09-24 | 17.930 | 18.010 | 17.550 | 17.640 | 17.640 | 1,404,336 |
| 2026-09-23 | 18.020 | 18.450 | 17.900 | 17.910 | 17.910 | 2,423,809 |
| 2026-09-22 | 18.290 | 18.440 | 18.000 | 18.090 | 18.090 | 4,004,311 |
| 2026-09-21 | 17.320 | 18.350 | 17.320 | 18.290 | 18.290 | 6,855,193 |
Page 1 of 1 · 20 trading days
Stock splits
No stock splits on record.
Dividends
| Ex-date | Amount |
|---|---|
| 2026-07-16 | 0.4500 HKD |
| 2025-07-24 | 0.3500 HKD |
| 2024-07-26 | 0.3000 HKD |
| 2023-07-31 | 0.4600 HKD |
| 2022-06-08 | 0.6600 HKD |
| 2021-07-07 | 0.5200 HKD |
| 2020-07-21 | 0.4300 HKD |
| 2019-07-24 | 0.3600 HKD |
Open, high, low and close are as traded (HKD). Adjusted close accounts for splits and dividends. Educational only, not financial advice.